Pathophysiology of Spinal Cord Injury and Tissue Engineering Approach for Its Neuronal Regeneration: Current Status and Future Prospects
- PMID: 36038807
- DOI: 10.1007/5584_2022_731
Pathophysiology of Spinal Cord Injury and Tissue Engineering Approach for Its Neuronal Regeneration: Current Status and Future Prospects
Abstract
A spinal cord injury (SCI) is a very debilitating condition causing loss of sensory and motor function as well as multiple organ failures. Current therapeutic options like surgery and pharmacotherapy show positive results but are incapable of providing a complete cure for chronic SCI symptoms. Tissue engineering, including neuroprotective or growth factors, stem cells, and biomaterial scaffolds, grabs attention because of their potential for regeneration and ability to bridge the gap in the injured spinal cord (SC). Preclinical studies with tissue engineering showed functional recovery and neurorestorative effects. Few clinical trials show the safety and efficacy of the tissue engineering approach. However, more studies should be carried out for potential treatment modalities. In this review, we summarize the pathophysiology of SCI and its current treatment modalities, including surgical, pharmacological, and tissue engineering approaches following SCI in preclinical and clinical phases.
Keywords: Neuroprotection; Neuroregeneration; Scaffolds; Spinal cord injury; Stem cells; Tissue engineering.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.
Similar articles
-
Biomaterial-supported MSC transplantation enhances cell-cell communication for spinal cord injury.Stem Cell Res Ther. 2021 Jan 7;12(1):36. doi: 10.1186/s13287-020-02090-y. Stem Cell Res Ther. 2021. PMID: 33413653 Free PMC article. Review.
-
Spinal Cord Repair: From Cells and Tissue Engineering to Extracellular Vesicles.Cells. 2021 Jul 23;10(8):1872. doi: 10.3390/cells10081872. Cells. 2021. PMID: 34440641 Free PMC article. Review.
-
Biomaterial scaffolds used for the regeneration of spinal cord injury (SCI).Histol Histopathol. 2014 Nov;29(11):1395-408. doi: 10.14670/HH-29.1395. Epub 2014 May 16. Histol Histopathol. 2014. PMID: 24831814 Review.
-
Current multi-scale biomaterials for tissue regeneration following spinal cord injury.Neurochem Int. 2024 Sep;178:105801. doi: 10.1016/j.neuint.2024.105801. Epub 2024 Jul 5. Neurochem Int. 2024. PMID: 38971503 Review.
-
Novel Strategies for Spinal Cord Regeneration.Int J Mol Sci. 2022 Apr 20;23(9):4552. doi: 10.3390/ijms23094552. Int J Mol Sci. 2022. PMID: 35562941 Free PMC article. Review.
Cited by
-
Efficacy of growth factor gene-modified stem cells for motor function after spinal cord injury in rodents: a systematic review and meta‑analysis.Neurosurg Rev. 2024 Feb 19;47(1):87. doi: 10.1007/s10143-024-02314-2. Neurosurg Rev. 2024. PMID: 38369598 Review.
-
S100A1 expression is increased in spinal cord injury and promotes inflammation, oxidative stress and apoptosis of PC12 cells induced by LPS via ERK signaling.Mol Med Rep. 2023 Feb;27(2):30. doi: 10.3892/mmr.2022.12917. Epub 2022 Dec 16. Mol Med Rep. 2023. PMID: 36524376 Free PMC article.
References
-
- Ahuja CS, Wilson JR, Nori S, Kotter MR, Druschel C, Curt A, Fehlings MG (2017) Nat Rev Dis Primers 3(1):1–21 - DOI
-
- Alizadeh A, Dyck SM, Karimi-Abdolrezaee S (2019) Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms. Front Neurol 22(10):282 - DOI
-
- Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, Franchina M, Lanzoni G, Cantoni S, Cavallini C, Bianchi F, Tazzari PL (2007) Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol 7(1):1–4 - DOI
-
- An N, Yang J, Wang H, Sun S, Wu H, Li L et al (2021) Mechanism of mesenchymal stem cells in spinal cord injury repair through macrophage polarization. Cell Biosci 11(1)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous